Clinical diagnosis and mutation analysis of a Chinese family with Camurati-Engelmann disease

7Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Camurati-Engelmann disease (CED) is a rare autosomal dominant bone disorder caused by a mutation in transforming growth factor β1 (TGFβ1). The present study aimed to identify a Chinese family with suspected CED based on the clinical symptoms, including pain in extremities, waddling gait, muscle weakness, cortical thickening of the diaphysis of the long bones, and sclerosis of the skull, facial bone, and pelvis. Molecular analysis revealed the presence of the p.Glu169Lys (E169K) mutation in exon 2 of TGFβ1 in patients when compared with the controls. Therefore, the Chinese family was diagnosed with CED due to the presence of the E169K mutation. The present study emphasized the importance of clinical and genetic evidence for the diagnosis of CED. The data presented in the present study are of significance to clinicians, as well as genetic counselors, in the prenatal screening of CED.

Cite

CITATION STYLE

APA

Chen, Y., Xie, W., Hu, F., Chen, J., Zheng, H., Zhou, H., … Zhou, J. (2017). Clinical diagnosis and mutation analysis of a Chinese family with Camurati-Engelmann disease. Molecular Medicine Reports, 15(1), 235–239. https://doi.org/10.3892/mmr.2016.6024

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free